Chembio Diagnostics Inc. announced Tuesday that it had signed agreements with two companies to develop rapid tests for dengue fever virus and an undisclosed type of cancer.
The Medford-based manufacturer of point-of-care tests for HIV and syphilis said the dengue partnership was concluded Monday, the same day that Chembio announced a partnership with Integrated BioTherapeutics Inc. of Maryland
No comments:
Post a Comment